These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11248095)

  • 41. Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice.
    Licht T; Goldenberg SK; Vieira WD; Gottesman MM; Pastan I
    Gene Ther; 2000 Feb; 7(4):348-58. PubMed ID: 10694816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Introduction of the green fluorescent protein gene into hematopoietic stem cells results in prolonged discrepancy of in vivo transduction levels between bone marrow progenitors and peripheral blood cells in nonhuman primates.
    Hanazono Y; Terao K; Shibata H; Nagashima T; Ageyama N; Asano T; Ueda Y; Kato I; Kume A; Hasegawa M; Ozawa K
    J Gene Med; 2002; 4(5):470-7. PubMed ID: 12221639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term inhibition of glycosphingolipid accumulation in Fabry model mice by a single systemic injection of AAV1 vector in the neonatal period.
    Ogawa K; Hirai Y; Ishizaki M; Takahashi H; Hanawa H; Fukunaga Y; Shimada T
    Mol Genet Metab; 2009 Mar; 96(3):91-6. PubMed ID: 19091614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene transfer and expression of human alpha-galactosidase from mouse muscle in vitro and in vivo.
    Novo FJ; Górecki DC; Goldspink G; MacDermot KD
    Gene Ther; 1997 May; 4(5):488-92. PubMed ID: 9274727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Local ex vivo gene therapy with bone marrow stromal cells expressing human BMP4 promotes endosteal bone formation in mice.
    Zhang XS; Linkhart TA; Chen ST; Peng H; Wergedal JE; Guttierez GG; Sheng MH; Lau KH; Baylink DJ
    J Gene Med; 2004 Jan; 6(1):4-15. PubMed ID: 14716672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.
    Eliopoulos N; Al-Khaldi A; Beauséjour CM; Momparler RL; Momparler LF; Galipeau J
    Gene Ther; 2002 Apr; 9(7):452-62. PubMed ID: 11938460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cells.
    Zhang J; Attar E; Cohen K; Crumpacker C; Scadden D
    Gene Ther; 2005 Oct; 12(19):1444-52. PubMed ID: 15877047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene.
    Hara T; Kume A; Hanazono Y; Mizukami H; Okada T; Tsurumi H; Moriwaki H; Ueda Y; Hasegawa M; Ozawa K
    Gene Ther; 2004 Sep; 11(18):1370-7. PubMed ID: 15229634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo expansion of gene-modified hematopoietic cells by a novel selective amplifier gene utilizing the erythropoietin receptor as a molecular switch.
    Nagashima T; Ueda Y; Hanazono Y; Kume A; Shibata H; Ageyama N; Terao K; Ozawa K; Hasegawa M
    J Gene Med; 2004 Jan; 6(1):22-31. PubMed ID: 14716674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
    Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M
    Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Promoter dependence of plasmid-pluronics targeted alpha galactosidase A expression in skeletal muscle of Fabry mice.
    Lavigne MD; Pohlschmidt M; Novo JF; Higgins B; Alakhov V; Lochmuller H; Sakuraba H; Goldspink G; MacDermot K; Górecki DC
    Mol Ther; 2005 Nov; 12(5):985-90. PubMed ID: 15975851
    [No Abstract]   [Full Text] [Related]  

  • 52. Distribution of alpha-galactosidase A in normal human kidney and renal accumulation and distribution of recombinant alpha-galactosidase A in Fabry mice.
    Christensen EI; Zhou Q; Sørensen SS; Rasmussen AK; Jacobsen C; Feldt-Rasmussen U; Nielsen R
    J Am Soc Nephrol; 2007 Mar; 18(3):698-706. PubMed ID: 17287429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Purification and characterization of human alpha-galactosidase A expressed in insect cells using a baculovirus vector.
    Chen Y; Jin M; Goodrich L; Smith G; Coppola G; Calhoun DH
    Protein Expr Purif; 2000 Nov; 20(2):228-36. PubMed ID: 11049747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor.
    Fan JQ; Ishii S; Asano N; Suzuki Y
    Nat Med; 1999 Jan; 5(1):112-5. PubMed ID: 9883849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele.
    Yasuda M; Shabbeer J; Benson SD; Maire I; Burnett RM; Desnick RJ
    Hum Mutat; 2003 Dec; 22(6):486-92. PubMed ID: 14635108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma.
    Froissart R; Guffon N; Vanier MT; Desnick RJ; Maire I
    Mol Genet Metab; 2003 Nov; 80(3):307-14. PubMed ID: 14680977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines.
    Richard E; Géronimi F; Lalanne M; Ged C; Redonnet-Vernhet I; Lamrissi-Garcia I; Gerson SL; de Verneuil H; Moreau-Gaudry F
    J Gene Med; 2003 Sep; 5(9):737-47. PubMed ID: 12950064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retroviral gene transfer and sustained expression of human arylsulfatase A.
    Learish R; Ohashi T; Robbins PA; Bahnson A; Boggs SS; Patrene K; Schwartz BE; Gieselmann V; Barranger JA
    Gene Ther; 1996 Apr; 3(4):343-9. PubMed ID: 8732166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model.
    Hanazono Y; Nagashima T; Takatoku M; Shibata H; Ageyama N; Asano T; Ueda Y; Dunbar CE; Kume A; Terao K; Hasegawa M; Ozawa K
    Gene Ther; 2002 Aug; 9(16):1055-64. PubMed ID: 12140733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myeloablation enhances engraftment of transduced murine hematopoietic cells, but does not influence long-term expression of the transgene.
    Puig T; Kádár E; Limón A; Cancelas JA; Eixarch H; Luquín L; García M; Barquinero J
    Gene Ther; 2002 Nov; 9(21):1472-9. PubMed ID: 12378410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.